Meta-Analysis: No Survival Benefit with Routine Revascularization in Stable Ischemic Heart Disease

Routine Revascularization versus Initial Medical Therapy for Stable Ischemic Heart Disease: A Systematic Review and Meta-Analysis of Randomized Trials – Circulation

Commentary: No Survival Benefit With Revascularization in Stable CAD, Meta-analysis Confirms – TCTMD

Related Commentary on Twitter

Meta-analysis of 14 RCTs of revasc vs. med tx in SIHD- no difference in death, no net difference MI, reduced USA/angina with revasc https://t.co/1TdRbVFn3m @SripalBangalore @AHAScience #PCReCourse #AHAJournals pic.twitter.com/I9yt4DHc8e

— Circulation (@CircAHA) June 26, 2020